AU Patent

AU2013200089B2 — Stable formulations, and methods of their preparation and use

Assigned to Santen Pharmaceutical Co Ltd · Expires 2016-03-03 · 10y expired

What this patent protects

Described herein are formulations comprising therapeutic agents, including but not limited to formulations comprising rapamycin, pharmaceutical formulations, unit dose forms, kits, methods of preparing formulations, and methods of using formulations. Such formulations and methods…

USPTO Abstract

Described herein are formulations comprising therapeutic agents, including but not limited to formulations comprising rapamycin, pharmaceutical formulations, unit dose forms, kits, methods of preparing formulations, and methods of using formulations. Such formulations and methods have increased stability. r CN t- CN tm a) 3 cc) CL) C) ra) C: D ) C C) C) : C C:> 0 oc ' c$~e; en j~

Drugs covered by this patent

Patent Metadata

Patent number
AU2013200089B2
Jurisdiction
AU
Classification
—
Expires
2016-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Santen Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.